Company Monitoring Page for Alnylam

latest headlines for company on cafepharma

Alnylam ratchets up Pfizer, Moderna infringement fight on same day it scored new patent
Fierce Pharma
Wed, 07/13/22 - 08:18 pm
Tags:
legal, Alnylam, Pfizer, Moderna Therapeutics, patents, vaccines
Alnylam wins FDA approval of rare disease drug in step toward profitability
BioPharma Dive
Tue, 06/14/22 - 11:14 am
Tags:
Alnylam, FDA, Amvuttra, hATTR amyloidosis
With Alzheimer's in its sights, Alnylam shares data on getting siRNA to targets beyond the liver
Fierce Pharma
Tue, 06/7/22 - 09:59 am
Tags:
Alnylam, siRNA, Alzheimer's disease, drug development
Pfizer shoots back at Alnylam's claims in high-stakes COVID-19 vaccine patent case
Fierce Pharma
Thu, 06/2/22 - 10:21 am
Tags:
Pfizer, Alnylam, vaccines, COVID-19, patents
Alnylam shoots for the heart
EP Vantage
Thu, 05/19/22 - 10:16 am
Tags:
Alnylam, Onpattro, ATTR amyloidosis
How a surprise finding made an Alnylam study one of biotech’s most ‘polarizing’ trials
BioPharma Dive
Tue, 04/26/22 - 10:31 am
Tags:
Alnylam, clinical trials, Onpattro, transthyretin amyloid cardiomyopathy
Alnylam's potential fourth RNAi approval delayed three months, but impact likely to be 'modest'
Endpoints
Mon, 04/4/22 - 11:08 pm
Tags:
Alnylam, RNAi, FDA, vutrisiran
The biggest launches of 2022: a reboot
EP Vantage
Mon, 02/14/22 - 10:48 am
Tags:
drug launches, Eli Lilly, tirzepatide, Alnylam, vutrisiran, Roche, Vabysmo, JNJ, Carvykti, Mirati Therapeutics, adagrasib, Bristol Myers Squibb, mavacamten, deucravacitinib
SFNP 2022 – Alnylam takes heart from its Onpattro follow-on
EP Vantage
Tue, 01/25/22 - 10:41 am
Tags:
Alnylam, vutrisiran, Onpattro, hereditary ATTR amyloidosis
Alnylam, awaiting key study data, builds case for its next rare disease drug
BioPharma Dive
Sat, 01/22/22 - 02:12 pm
Tags:
Alnylam, ATTR, vutrisiran
7 drugs likely to hit $1B in annual revenue in the next 5 years
Beckers Hospital Review
Thu, 01/13/22 - 07:31 am
Tags:
FDA, adagrasib, donanemab, faricimab, lecanemab, tezepelumab, tirzepatide, vutrisiran, Eli Lilly, Mirati Therapeutics, Roche, Chugai, Eisai, Biogen, AstraZeneca, Amgen, Alnylam
Where will Novartis spend the $21B from Roche stake sale? Alnylam buyout could be one: report
Fierce Pharma
Thu, 11/18/21 - 10:50 am
Tags:
Novartis, Roche, M&A, Alnylam
What Novartis could buy with its windfall
EP Vantage
Fri, 11/5/21 - 09:40 am
Tags:
Novartis, M&A, Roche, Sandoz, Aurinia Pharmaceuticals, Alnylam, Exelixis, Incyte, Eisai, Genmab
Alnylam Announces Planned CEO Leadership Transition
Yahoo Finance
Thu, 10/28/21 - 10:42 am
Tags:
Alnylam, earnings, Pharma CEOs, John Maraganore
Dicerna can’t catch up with Alnylam
EP Vantage
Mon, 08/9/21 - 10:50 am
Tags:
Dicerna, Primary Hyperoxaluria, Alnylam, nedosiran
Alnylam's Study on Renal Treatment Shows Promising Results In Phase III Trial
BioSpace
Mon, 08/2/21 - 11:06 am
Tags:
Alnylam, RNAi, renal decline, clinical trials, lumasiran
A 'springboard' to the future: Genentech, Sanofi and Alnylam execs sound off on pharma's evolving back-to-work plans
Fierce Pharma
Wed, 05/26/21 - 12:05 am
Tags:
pandemic, COVID-19, Genentech, Sanofi, Alnylam, remote work, human resources
The "Rare Disease Company Coalition" Launches to Share the Unique Challenges and Promise of Rare Disease Therapy Development to Support Continued Progress and Patient Access
Yahoo/Businesswire
Thu, 05/13/21 - 12:04 pm
Tags:
Rare Diseases, Rare Disease Company Coalition, drug development, drug discovery, Acceleron, Aeglea BioTherapeutics, Agios Pharmaceuticals, Alnylam, Harmony Biosciences, Orchard Therapeutics, Orphazyme, Sarepta Therapeutics, Taysha Gene Therapies, Ultragenyx
Alnylam provides long-term look at Oxlumo, aiming to further carve out stake in PH1 market
Endpoints
Tue, 05/4/21 - 10:38 am
Tags:
Alnylam, Oxlumo, Primary Hyperoxaluria, clinical trials
AAN 2021 – Helios backs Alnylam’s sunny forecasts
EP Vantage
Wed, 04/21/21 - 10:28 am
Tags:
Alnylam, AAN, vutrisiran, Onpattro, hATTR amyloidosis

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.